Nonalcoholic fatty liver disease (NAFLD) accounts for most cases of chronic liver disease
worldwide, with an estimated global prevalence of approximately 25% and ranges from …

Non-alcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese subjects;
however, it is not rare among lean individuals. Given the absence of traditional risk factors, it …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease,
encompassing a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis …

Non-alcoholic fatty liver disease (NAFLD) parallels comorbidities such as metabolic
syndrome, dyslipidaemia or diabetes. Although NAFLD is very prevalent in overweight …

Abstract Classically, Non-Alcoholic Fatty Liver Disease (NAFLD) has been thought to be
driven by excessive weight gain and obesity. The overall greater awareness of this disorder …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with
an estimated prevalence of 25% globally. NAFLD is closely associated with metabolic …

The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased rapidly and is
associated with obesity in epidemiology and pathogenesis. A new study reports that hepatic …

Background & Aims Nonalcoholic fatty liver disease (NAFLD) is traditionally associated with
obesity. However, there is a subtype of NAFLD, namely NAFLD in lean, that occurs without …

Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects
of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public …

Background & aims Non-alcoholic fatty liver disease (NAFLD), with its increasing prevalence
and association with various co-morbidities, such as diabetes, cardiovascular disease and …